🇺🇸 FDA
Patent

US 11884736

Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)

granted A61KA61K2039/505A61K2039/54

Quick answer

US patent 11884736 (Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K2039/54, A61K9/0019, A61P